Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Heras-Garvin

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Parkinsonism & Related Disorders|February 2, 2020
MSA: From basic mechanisms to experimental therapeuticsAntonio Heras-Garvin, Nadia Stefanova
Frontiers in Synaptic Neuroscience|October 19, 2020
From Synaptic Protein to Prion: The Long and Controversial Journey of α-SynucleinAntonio Heras-Garvin, Nadia Stefanova
Frontiers in Neurology|October 22, 2021
The Concept of α-Synuclein Strains and How Different Conformations May Explain Distinct Neurodegenerative DisordersKatja Malfertheiner, Nadia Stefanova, Antonio Heras-Garvin
Journal of Neuroinflammation|January 26, 2020
High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathyAntonio Heras-Garvin, Violetta Refolo, Markus Reindl, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 15, 2025
Transcriptional dysregulation in the cerebellum triggered by oligodendroglial α-synucleinopathy: insights from a transgenic mouse into the early disease mechanisms of MSAAntonio Heras-Garvin, Lisa Fellner, Roberta Granata, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 4, 2020
Signs of Chronic Hypoxia Suggest a Novel Pathophysiological Event in α-SynucleinopathiesAntonio Heras-Garvin, Christoph Danninger, Sabine Eschlböck, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 8, 2021
ATH434 Reduces α-Synuclein-Related Neurodegeneration in a Murine Model of Multiple System AtrophyAntonio Heras-Garvin, Violetta Refolo, Claudio Schmidt, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 20, 2018
Anle138b modulates α-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophyAntonio Heras-Garvin, Daniel Weckbecker, Sergey Ryazanov, et al.
NPJ Parkinson'S Disease|May 25, 2026
Multiparametric MRI and imaging transcriptomics reveal molecular and cellular correlates of neurodegeneration in experimental ParkinsonismEugene Kim, Diana Cash, Daniel Martins, et al.
Translational Neurodegeneration|September 25, 2020
Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevanceMiguel Lemos, Serena Venezia, Violetta Refolo, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Parkinsonism & Related Disorders|February 2, 2020
MSA: From basic mechanisms to experimental therapeuticsAntonio Heras-Garvin, Nadia Stefanova
Frontiers in Synaptic Neuroscience|October 19, 2020
From Synaptic Protein to Prion: The Long and Controversial Journey of α-SynucleinAntonio Heras-Garvin, Nadia Stefanova
Frontiers in Neurology|October 22, 2021
The Concept of α-Synuclein Strains and How Different Conformations May Explain Distinct Neurodegenerative DisordersKatja Malfertheiner, Nadia Stefanova, Antonio Heras-Garvin
Journal of Neuroinflammation|January 26, 2020
High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathyAntonio Heras-Garvin, Violetta Refolo, Markus Reindl, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 15, 2025
Transcriptional dysregulation in the cerebellum triggered by oligodendroglial α-synucleinopathy: insights from a transgenic mouse into the early disease mechanisms of MSAAntonio Heras-Garvin, Lisa Fellner, Roberta Granata, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 4, 2020
Signs of Chronic Hypoxia Suggest a Novel Pathophysiological Event in α-SynucleinopathiesAntonio Heras-Garvin, Christoph Danninger, Sabine Eschlböck, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 8, 2021
ATH434 Reduces α-Synuclein-Related Neurodegeneration in a Murine Model of Multiple System AtrophyAntonio Heras-Garvin, Violetta Refolo, Claudio Schmidt, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 20, 2018
Anle138b modulates α-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophyAntonio Heras-Garvin, Daniel Weckbecker, Sergey Ryazanov, et al.
NPJ Parkinson'S Disease|May 25, 2026
Multiparametric MRI and imaging transcriptomics reveal molecular and cellular correlates of neurodegeneration in experimental ParkinsonismEugene Kim, Diana Cash, Daniel Martins, et al.
Translational Neurodegeneration|September 25, 2020
Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevanceMiguel Lemos, Serena Venezia, Violetta Refolo, et al.
Pageof 2